130 related articles for article (PubMed ID: 16279793)
1. Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach to designing exopeptidase inhibitors.
Ganellin CR; Bishop PB; Bambal RB; Chan SM; Leblond B; Moore AN; Zhao L; Bourgeat P; Rose C; Vargas F; Schwartz JC
J Med Chem; 2005 Nov; 48(23):7333-42. PubMed ID: 16279793
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of tripeptidyl peptidase II. 2. Generation of the first novel lead inhibitor of cholecystokinin-8-inactivating peptidase: a strategy for the design of peptidase inhibitors.
Ganellin CR; Bishop PB; Bambal RB; Chan SM; Law JK; Marabout B; Luthra PM; Moore AN; Peschard O; Bourgeat P; Rose C; Vargas F; Schwartz JC
J Med Chem; 2000 Feb; 43(4):664-74. PubMed ID: 10691692
[TBL] [Abstract][Full Text] [Related]
3. Characterization and inhibition of a cholecystokinin-inactivating serine peptidase.
Rose C; Vargas F; Facchinetti P; Bourgeat P; Bambal RB; Bishop PB; Chan SM; Moore AN; Ganellin CR; Schwartz JC
Nature; 1996 Apr; 380(6573):403-9. PubMed ID: 8602240
[TBL] [Abstract][Full Text] [Related]
4. Inhibitor-based validation of a homology model of the active-site of tripeptidyl peptidase II.
De Winter H; Breslin H; Miskowski T; Kavash R; Somers M
J Mol Graph Model; 2005 Apr; 23(5):409-18. PubMed ID: 15781183
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and tripeptidyl peptidase II inhibitory activity of a novel series of (S)-2,3-dihydro-2-(4-alkyl-1H-imidazol-2-yl)-1H-indoles.
Breslin HJ; Miskowski TA; Kukla MJ; Leister WH; De Winter HL; Gauthier DA; Somers MV; Peeters DC; Roevens PW
J Med Chem; 2002 Nov; 45(24):5303-10. PubMed ID: 12431057
[TBL] [Abstract][Full Text] [Related]
6. Tripeptidyl peptidase-I is essential for the degradation of sulphated cholecystokinin-8 (CCK-8S) by mouse brain lysosomes.
Warburton MJ; Bernardini F
Neurosci Lett; 2002 Oct; 331(2):99-102. PubMed ID: 12361850
[TBL] [Abstract][Full Text] [Related]
7. Association and dissociation of the tripeptidyl-peptidase II complex as a way of regulating the enzyme activity.
Tomkinson B
Arch Biochem Biophys; 2000 Apr; 376(2):275-80. PubMed ID: 10775413
[TBL] [Abstract][Full Text] [Related]
8. Use of a dehydroalanine-containing peptide as an efficient inhibitor of tripeptidyl peptidase II.
Tomkinson B; Grehn L; Fransson B; Zetterqvist O
Arch Biochem Biophys; 1994 Nov; 314(2):276-9. PubMed ID: 7979365
[TBL] [Abstract][Full Text] [Related]
9. Tripeptidyl-peptidase II: a multi-purpose peptidase.
Tomkinson B; Lindås AC
Int J Biochem Cell Biol; 2005 Oct; 37(10):1933-7. PubMed ID: 16125107
[TBL] [Abstract][Full Text] [Related]
10. Tripeptidyl-peptidase II (TPP II) inhibitory activity of (S)-2,3-dihydro-2-(1H-imidazol-2-yl)-1H-indoles, a systematic SAR evaluation. Part 2.
Breslin HJ; Miskowski TA; Kukla MJ; De Winter HL; Somers MV; Roevens PW; Kavash RW
Bioorg Med Chem Lett; 2003 Dec; 13(24):4467-71. PubMed ID: 14643348
[TBL] [Abstract][Full Text] [Related]
11. Axonal transports of tripeptidyl peptidase II in rat sciatic nerves.
Chikuma T; Shimizu M; Tsuchiya Y; Kato T; Hojo H
Neurochem Int; 2007 Jan; 50(1):236-42. PubMed ID: 17023090
[TBL] [Abstract][Full Text] [Related]
12. Tripeptidyl peptidase II is dispensable for the generation of both proteasome-dependent and proteasome-independent ligands of HLA-B27 and other class I molecules.
Marcilla M; Villasevil EM; de Castro JA
Eur J Immunol; 2008 Mar; 38(3):631-9. PubMed ID: 18286573
[TBL] [Abstract][Full Text] [Related]
13. Is there a tripeptidyl peptidase in the renal brush-border membrane?
Kenny AJ; Ingram J
Biochem J; 1988 Oct; 255(1):373-6. PubMed ID: 3058122
[TBL] [Abstract][Full Text] [Related]
14. Human dipeptidyl peptidase III acts as a post-proline-cleaving enzyme on endomorphins.
Barsun M; Jajcanin N; Vukelić B; Spoljarić J; Abramić M
Biol Chem; 2007 Mar; 388(3):343-8. PubMed ID: 17338643
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and use of 4-peptidylhydrazido-N-hexyl-1,8-naphthalimides as fluorogenic histochemical substrates for dipeptidyl peptidase IV and tripeptidyl peptidase I.
Ivanov I; Tasheva D; Todorova R; Dimitrova M
Eur J Med Chem; 2009 Jan; 44(1):384-92. PubMed ID: 18410982
[TBL] [Abstract][Full Text] [Related]
16. S 17092-1, a highly potent, specific and cell permeant inhibitor of human proline endopeptidase.
Barelli H; Petit A; Hirsch E; Wilk S; De Nanteuil G; Morain P; Checler F
Biochem Biophys Res Commun; 1999 Apr; 257(3):657-61. PubMed ID: 10208839
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and SAR of potent and selective dipeptide-derived inhibitors for dipeptidyl peptidases.
Senten K; Van der Veken P; De Meester I; Lambeir AM; Scharpé S; Haemers A; Augustyns K
J Med Chem; 2003 Nov; 46(23):5005-14. PubMed ID: 14584950
[TBL] [Abstract][Full Text] [Related]
18. Role of tripeptidyl peptidase II in MHC class I antigen processing - the end of controversies?
Endert Pv
Eur J Immunol; 2008 Mar; 38(3):609-13. PubMed ID: 18286570
[TBL] [Abstract][Full Text] [Related]
19. Purification and characterization of tripeptidyl peptidase I from Dictyostelium discoideum.
Krimper RP; Jones TH
Biochem Mol Biol Int; 1999 Jun; 47(6):1079-88. PubMed ID: 10410254
[TBL] [Abstract][Full Text] [Related]
20. Dipeptide boronic acid inhibitors of dipeptidyl peptidase IV: determinants of potency and in vivo efficacy and safety.
Connolly BA; Sanford DG; Chiluwal AK; Healey SE; Peters DE; Dimare MT; Wu W; Liu Y; Maw H; Zhou Y; Li Y; Jin Z; Sudmeier JL; Lai JH; Bachovchin WW
J Med Chem; 2008 Oct; 51(19):6005-13. PubMed ID: 18783201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
